Quinapril (Cipla USA Inc.)
Welcome to the PulseAid listing for the Quinapril drug offered from Cipla USA Inc.. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cipla USA Inc. |
NON-PROPRIETARY NAME: | Quinapril |
SUBSTANCE NAME: | QUINAPRIL HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-07-22 |
END MARKETING DATE: | 0000-00-00 |
Quinapril HUMAN PRESCRIPTION DRUG Details:
Item Description | Quinapril from Cipla USA Inc. |
LABELER NAME: | Cipla USA Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2016-07-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69097-839_b1bc5d1c-af0b-46a3-b116-c980f3009dfb |
PRODUCT NDC: | 69097-839 |
APPLICATION NUMBER: | ANDA078457 |
Other QUINAPRIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: